The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 05, 2016
Filed:
Feb. 12, 2013
Applicant:
Takeda Pharmaceutical Company Limited, Osaka, JP;
Inventors:
Seiji Miwatashi, Tokyo, JP;
Hideo Suzuki, Kanagawa, JP;
Tomohiro Okawa, Kanagawa, JP;
Yasufumi Miyamoto, Kanagawa, JP;
Takeshi Yamasaki, Kanagawa, JP;
Yuko Hitomi, Kanagawa, JP;
Yasuhiro Hirata, Kanagawa, JP;
Akito Shibuya, Kanagawa, JP;
Assignee:
TAKEDA PHARMACEUTICAL COMPANY LIMITED, Osaka, JP;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07C 59/135 (2006.01); C07D 405/14 (2006.01); C07C 255/46 (2006.01); C07D 309/06 (2006.01); C07D 231/12 (2006.01); C07D 333/38 (2006.01); C07D 401/12 (2006.01); C07D 239/26 (2006.01); C07D 239/34 (2006.01); C07C 317/44 (2006.01); C07C 229/34 (2006.01); C07C 233/47 (2006.01); C07D 271/10 (2006.01); C07D 277/24 (2006.01); C07C 255/37 (2006.01); C07D 285/12 (2006.01); C07D 213/30 (2006.01); C07D 213/55 (2006.01); C07D 213/64 (2006.01); C07D 213/65 (2006.01); C07D 213/68 (2006.01); C07D 213/69 (2006.01); C07C 59/68 (2006.01); C07C 59/70 (2006.01); C07C 59/72 (2006.01); C07D 213/12 (2006.01); C07C 309/65 (2006.01); C07C 309/66 (2006.01); C07C 311/21 (2006.01); C07C 323/56 (2006.01); C07C 235/34 (2006.01); C07C 255/41 (2006.01);
U.S. Cl.
CPC ...
C07C 59/135 (2013.01); C07C 59/68 (2013.01); C07C 59/70 (2013.01); C07C 59/72 (2013.01); C07C 229/34 (2013.01); C07C 233/47 (2013.01); C07C 235/34 (2013.01); C07C 255/37 (2013.01); C07C 255/41 (2013.01); C07C 255/46 (2013.01); C07C 309/65 (2013.01); C07C 309/66 (2013.01); C07C 311/21 (2013.01); C07C 317/44 (2013.01); C07C 323/56 (2013.01); C07D 213/12 (2013.01); C07D 213/30 (2013.01); C07D 213/55 (2013.01); C07D 213/64 (2013.01); C07D 213/65 (2013.01); C07D 213/68 (2013.01); C07D 213/69 (2013.01); C07D 231/12 (2013.01); C07D 239/26 (2013.01); C07D 239/34 (2013.01); C07D 271/10 (2013.01); C07D 277/24 (2013.01); C07D 285/12 (2013.01); C07D 309/06 (2013.01); C07D 333/38 (2013.01); C07D 401/12 (2013.01); C07D 405/14 (2013.01); C07C 2101/02 (2013.01); C07C 2101/04 (2013.01); C07C 2101/08 (2013.01);
Abstract
Provided is an aromatic ring compound having a GPR40 agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the DESCRIPTION, or a salt thereof has a GPR40 agonist activity, and is useful as an agent for the prophylaxis or treatment of diabetes and the like.